Identification of RHEX as a novel biomarker related to progression and immunity of non-small cell lung carcinoma

被引:1
作者
Xu, Tao [1 ]
Dai, Tianyang [1 ]
Zeng, Peiyuan [1 ]
Song, Qi [1 ]
He, Kaiming [1 ]
Hu, Zhi [1 ]
Li, Yuan [1 ]
Li, Zhou [1 ]
机构
[1] Southwest Med Univ, Dept Thorac Surg, Affiliated Hosp, 25 Taiping St, Luzhou 646000, Peoples R China
关键词
Non-small cell lung carcinoma (NSCLC); regulator of hemoglobinization and erythroid cell expansion (RHEX); single-sample gene set enrichment analysis (ssGSEA); weighted gene co-expression network analysis (WGCNA); CD8(+) T-CELLS; PROLIFERATION; GLYCOLYSIS; NSCLC; CYCLE; MYC;
D O I
10.21037/tcr-21-1316
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The therapeutic response and prognosis of patients with non-small cell lung carcinoma (NSCLC) are widely related to immunity. To improve the prognosis of patients and provide reliable information to guide appropriate personalized treatment strategies, it is necessary to identify reliable prognostic or predictive indicators closely related to tumor phenotype and immune traits in NSCLC. Methods: Based on The Cancer Genome Atlas (TCGA)-NSCLC mRNA expression profile data, a novel approach combining differential gene expression analysis, single-sample gene set enrichment analysis (ssGSEA), and weighted gene co-expression network analysis (WGCNA) was used to screen hub genes. Subsequently, the regulator of hemoglobinization and erythroid cell expansion (RHEX) was identified as a key gene using the log-rank test and confirmed in the ArrayExpress database. The relationship between RHEX and clinicopathological parameters was analyzed using the Wilcoxon rank-sum test. More importantly, through gene set enrichment analysis (GSEA) and cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT) algorithms, and with reference to the Tumor IMmune Estimation Resource (TIMER) database, we explored the relevant pathways of RHEX and its relationship with tumor-infiltrating immune cells (TICs). Finally, we depicted the association between RHEX and immunomodulators in the TCGA and a web portal TISIDB. Results: The RHEX mRNA expression levels in tumor tissues were lower than those in normal tissues and declined with the progression of NSCLC. Meanwhile, RHEX overexpression was associated with high immune infiltration levels and a favorable clinical prognosis. RHEX may participate in tumor microenvironment (TME) regulation through multiple tumor-immune related pathways, especially the JAK -STAT signaling pathway. Furthermore, RHEX expression affected the infiltrating abundance of multiple TICs and positively correlated with most of the immunomodulators in NSCLC. Conclusions: Our study is the first to propose that RHEX is an immune-related gene with prognostic value in NSCLC and reveals the underlying mechanism between RHEX and tumor-immune system interactions. These results ultimately provide guidance for prognosis and immunotherapy for NSCLC patients.
引用
收藏
页码:3811 / +
页数:22
相关论文
共 45 条
[31]   PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups [J].
Schmidt, Lars Henning ;
Kuemmel, Andreas ;
Goerlich, Dennis ;
Mohr, Michael ;
Broeckling, Sebastian ;
Mikesch, Jan Henrik ;
Gruenewald, Inga ;
Marra, Alessandro ;
Schultheis, Anne M. ;
Wardelmann, Eva ;
Mueller-Tidow, Carsten ;
Spieker, Tilmann ;
Schliemann, Christoph ;
Berdel, Wolfgang E. ;
Wiewrodt, Rainer ;
Hartmann, Wolfgang .
PLOS ONE, 2015, 10 (08)
[32]   Cancer cell cycles [J].
Sherr, CJ .
SCIENCE, 1996, 274 (5293) :1672-1677
[33]   RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development [J].
Verma, Rakesh ;
Su, Su ;
McCrann, Donald J. ;
Green, Jennifer M. ;
Leu, Karen ;
Young, Peter R. ;
Schatz, Peter J. ;
Silva, Jeffrey C. ;
Stokes, Matthew P. ;
Wojchowski, Don M. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 211 (09) :1715-1722
[34]   Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC [J].
Wang, Huaqi ;
Wang, Lei ;
Zhang, Shijie ;
Xu, Zhexuan ;
Zhang, Guojun .
BIOMEDICINE & PHARMACOTHERAPY, 2020, 127
[35]   Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer [J].
Wang, Qinchaung ;
Gu, Jianchun ;
Wang, Linbo ;
Chang, David W. ;
Ye, Yuanqing ;
Huang, Maosheng ;
Roth, Jack A. ;
Wu, Xifeng .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
[36]  
Watowich SS, 2011, J INVEST MED, V59, P1067, DOI 10.2310/JIM.0b013e31820fb28c
[37]   Erythropoietin receptor response circuits [J].
Wojchowski, Don M. ;
Sathyanarayana, Pradeep ;
Dev, Arvind .
CURRENT OPINION IN HEMATOLOGY, 2010, 17 (03) :169-176
[38]   The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets [J].
Wood, Steven L. ;
Pernemalm, Maria ;
Crosbie, Philip A. ;
Whetton, Anthony D. .
CANCER TREATMENT REVIEWS, 2014, 40 (04) :558-566
[39]   Effects of single-nucleotide polymorphisms in the mTORC1 pathway on the risk of brain metastasis in patients with non-small cell lung cancer [J].
Xu, Yiquan ;
Huang, Yina ;
Weng, Lihong ;
Zheng, Jiankun ;
Huang, Yi ;
Lin, Ying ;
Zhao, Yunan ;
Li, Hongru ;
Chen, Yusheng .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (01) :273-285
[40]   NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells [J].
Zeng, Cheng ;
Wu, Qipeng ;
Wang, Jing ;
Yao, Bei ;
Ma, Lei ;
Yang, Zhicheng ;
Li, Juan ;
Liu, Bing .
FREE RADICAL BIOLOGY AND MEDICINE, 2016, 101 :236-248